Ofev 100 — Nintedanib 100 mg (60 Capsules)
Ofev 100 mg (Nintedanib) is a modern anti-fibrotic medication designed to slow the progression of severe interstitial lung diseases. Nintedanib blocks the activity of specific receptors (tyrosine kinases) that stimulate the growth and division of fibroblasts — cells responsible for the formation of scar tissue in the lungs. The 100 mg dosage allows the physician to individually tailor effective therapy, ensuring a balance between therapeutic action and drug tolerability.
Manufacturer: Boehringer Ingelheim, Germany. Ofev is the standard of care for fibrosing lung diseases, helping patients preserve respiratory function and reduce the risk of exacerbations that lead to a sharp deterioration in health.
Key Features:
- ✅ Therapeutic Flexibility: The 100 mg dosage is often used for patients with increased sensitivity to the drug or when dose adjustment is necessary due to side effects.
- ✅ Targeted Mechanism: Acts directly on the mechanisms of pulmonary fibrosis formation (VEGFR, FGFR, PDGFR).
- ✅ Clinically Proven Effect: Significantly slows the annual decline in forced vital capacity (FVC).
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 04.06.2026
Similar products
What Customers Say
No reviews yet
Your review can be the first!